Quantum and molecular dynamics study for binding of macrocyclic inhibitors to human α-thrombin

Biophysical Journal

Volumn 92, Issue 12, 2007, Pages 4244-4253

  Wu, Emilia L ^a   Mei, Ye ^b   Han, KeLi ^a   Zhang, John Z H ^b,c  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b NANJING UNIVERSITY   (China)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN;

ARTICLE; CHEMICAL STRUCTURE; HUMAN; LIGAND BINDING; MOLECULAR DYNAMICS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; QUANTUM MECHANICS;

EID: 34250337807     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.106.099150     Document Type: Article

References (49)

1. Davie, E. W., K. Fujikawa, and W. Kisiel. 1991. The coagulation cascade - initiation, maintenance, and regulation. Biochemistry. 30:10363-10370.
2. Pierce, A. C., and W. L. Jorgensen. 2001. Estimation of binding affinities for selective thrombin inhibitors via Monte Carlo simulations. J. Med. Chem. 44:1043-1050.
3. Vu, T. K. H., D. T. Hung, V. I. Wheaton, and S. R. Coughlin. 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1057-1068.
4. Fenton, J. W., F. A. Ofosu, D. G. Moon, and J. M. Maraganore. 1991. Thrombin structure and function - why thrombin is the primary target for antithrombotics. Blood Coagul. Fibrinolysis. 2:69-75.
5. Raskob, G. E., and J. N. George. 1997. Thrombotic complications of antithrombotic therapy: a paradox with implications for clinical practice. Ann. Intern. Med. 127:839-841.
6. Thomas, D. J. http://www.fda.gov/cder/foi/appletter/2000/20883ltr.pdf (7/1/2000UT).
7. Bizios, R., L. Lai, J. W. Fenton, and A. B. Malik. 1986. Thrombin-induced chemotaxis and aggregation of neutrophils. J. Cell. Physiol. 128:485-490.
8. Steiner, J. L. R., M. Murakami, and A. Tulinsky. 1998. Structure of thrombin inhibited by aeruginosin 298-A from a blue-green alga. J. Am. Chem. Soc. 120:597-598.
9. Costanzo, M. J., H. R. Almond, L. R. Hecker, M. R. Schott, S. C. Yabut, H. C. Zhang, P. Andrade-Gordon, T. W. Corcoran, E. C. Giardino, J. A. Kauffman, J. M. Lewis, L. de Garavilla, B. J. Haertlein, and B. E. Maryanoff. 2005. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S-1′ subsite and its implications to structure-based drug design. J. Med. Chem. 48:1984-2008.
10. Thorstensson, F., I. Kvarnstrom, D. Musil, I. Nilsson, and B. Samuelsson. 2003. Synthesis of novel thrombin inhibitors. Use of ring-closing metathesis reactions for synthesis of P2 cyclopentene- and cyclohexenedicarboxylic acid derivatives. J. Med. Chem. 46:1165-1179.
11. Young, M. B., J. C. Barrow, K. L. Glass, G. F. Lundell, C. L. Newton, J. M. Pellicore, K. E. Rittle, H. G. Selnick, K. J. Stauffer, J. P. Vacca, P. D. Williams, D. Bohn, F. C. Clayton, J. J. Cook, J. A. Krueger, L. C. Kuo, S. D. Lewis, B. J. Lucas, D. R. McMasters, C. Miller-Stein, B. L. Pietrak, A. A. Wallace, R. B. White, B. Wong, Y. W. Yan, and P. G. Nantermet. 2004. Discovery and evaluation of potent P-1 aryl heterocycle-based thrombin inhibitors. J. Med. Chem. 47:2995-3008.
12. Jones Hertzog, D. K., and W. L. Jorgensen. 1997. Binding affinities for sulfonamide inhibitors with human thrombin using Monte Carlo simulations with a linear response method. J. Med. Chem. 40:1539-1549.
13. Linusson, A., J. Gottfries, T. Olsson, E. Ornskov, S. Folestad, B. Norden, and S. Wold. 2001. Statistical molecular design, parallel synthesis, and biological evaluation of a library of thrombin inhibitors. J. Med. Chem. 44:3424-3439.
14. Bode, W., I. Mayr, U. Baumann, R. Huber, S. R. Stone, and J. Hofsteenge. 1989. The refined 1.9 Å crystal structure of human α-thrombin - interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 8:3467-3475.
15. Nilsson, J. W., I. Kvarnstrom, D. Musil, I. Nilsson, and B. Samuelsson. 2003. Synthesis and SAR of thrombin inhibitors incorporating a novel 4-amino-morpholinone scaffold: analysis of x-ray crystal structure of enzyme inhibitor complex. J. Med. Chem. 46:3985-4001.
16. Grootenhuis, P. D. J., and P. J. M. Vangalen. 1995. Correlation of binding affinities with nonbonded interaction energies of thrombin-inhibitor complexes. Acta Crystallogr. D Biol. Crystallogr. 51:560-566.
17. Grootenhuis, P. D. J., and M. Karplus. 1996. Functionality map analysis of the active site cleft of human thrombin. J. Comput.Aided Mol. Des. 10:1-10.
18. Bohm, M., J. Sturzebecher, and G. Klebe. 1999. Three-dimensional quantitative structure-activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa. J. Med. Chem. 42:458-477.
19. Nantermet, P. G., J. C. Barrow, C. L. Newton, J. M. Pellicore, M. B. Young, S. D. Lewis, B. J. Lucas, J. A. Krueger, D. R. McMasters, Y. W. Yan, L. C. Kuo, J. P. Vacca, and H. G. Selnick. 2003. Design and synthesis of potent and selective macrocyclic thrombin inhibitors. Bioorg. Med. Chem. Lett. 13:2781-2784.
20. Tucker, T. J., S. F. Brady, W. C. Lumma, S. D. Lewis, S. J. Gardell, A. M. Naylor-Olsen, Y. W. Yan, J. T. Sisko, K. J. Stauffer, B. J. Lucas, J. J. Lynch, J. J. Cook, M. T. Stranieri, M. A. Holahan, E. A. Lyle, E. P. Baskin, I. W. Chen, K. B. Dancheck, J. A. Krueger, C. M. Cooper, and J. P. Vacca. 1998. Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position. J. Med. Chem. 41:3210-3219.
21. Tucker, T. J., W. C. Lumma, A. M. Mulichak, Z. G. Chen, A. M. Naylor-Olsen, S. D. Lewis, R. Lucas, R. M. Freidinger, and L. C. Kuo. 1997. Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site. J. Med. Chem. 40:830-832.
22. Zhang, D. W., Y. Xiang, and J. Z. H. Zhang. 2003. New advance in computational chemistry: full quantummechanical ab initio computation of streptavidin-biotin interaction energy. J. Phys. Chem. B. 107:12039-12041.
23. Zhang, D. W., and J. Z. H. Zhang. 2003. Molecular fractionation with conjugate caps for full quantum mechanical calculation of protein-molecule interaction energy. J. Chem. Phys. 119:3599-3605.
24. He, X., Y. Mei, Y. Xiang, D. W. Zhang, and J. Z. H. Zhang. 2005. Quantum computational analysis for drug resistance of HIV-1 reverse transcriptase to nevirapine through point mutations. Proteins Structure Function Bioinformatics. 61:423-432.
25. Mei, Y., X. He, Y. Xiang, D. W. Zhang, and J. Z. H. Zhang. 2005. Quantum study of mutational effect in binding of efavirenz to HIV-1 RT. Proteins Structure Function Bioinformatics. 59:489-495.
26. Zhang, D. W., Y. Xiang, A. M. Gao, and J. Z. H. Zhang. 2004. Quantum mechanical map for protein-ligand binding with application to beta-trypsin/benzamidine complex. J. Chem. Phys. 120:1145-1148.
27. Chen, X. H., D. W. Zhang, and J. Z. H. Zhang. 2004. Fractionation of peptide with disulfide bond for quantum mechanical calculation of interaction energy with molecules. J. Chem. Phys. 120:839-844.
28. Case, D. A., T. E. Cheatham III, C. L. Simmerling, J. Wang, R. E. Duke, R. Luo, K. M. Merz, B. Wang, D. A. Pearlman, M. Crowley, S. Brozell, V. Tsui, H. Gohlke, J. Mongan, V. Hornak, G. Cui, P. Beroza, C. Schafmeister, J. W. Caldwell, W. S. Ross, and P. A. Kollman. AMBER8. 2004. University of California, San Francisco, CA.
29. Wang, J. M., P. Cieplak, and P. A. Kollman. 2000. How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? J. Comput. Chem. 21:1049-1074.
30. Darden, T., D. York, and L. Pedersen. 1993. Particle mesh Ewald - an N-log(N) method for Ewald sums in large systems. J. Chem. Phys. 98:10089-10092.
31. Ryckaert, J. P., G. Ciccotti, and H. J. C. Berendsen. 1977. Numerical-integration of Cartesian equations of motion of a system with constraints - molecular dynamics of n-alkanes. J. Comput. Phys. 23:327-341.
32. Gohlke, H., C. Kiel, and D. A. Case. 2003. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RaIGDS complexes. J. Mol. Biol. 330:891-913.
33. Frish, M. J., H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, J. A. Montgomery, Jr., T. Vreven, K. N. Kudin, J. C. Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J.E. Knox, H. P. Hratchian, J. B. Cross, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J. Dannenberg, V.G. Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cioslowski, B. B. Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. A. Al-Laham, C. Y. Peng, A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W. Chen, M. W. Wong, C. Gonzalez, and J. A. Pople. Gaussian 03, Rev. B.05. 2003. Gaussian, Inc. Pittsburgh, PA.
34. Beveridge, D. L., and F. M. Dicapua. 1989. Free-energy via molecular simulation - applications to chemical and biomolecular systems. Annu. Rev. Biophys. Biophys. Chem. 18:431-492.
35. Kollman, P. 1993. Free-energy calculations - applications to chemical and biochemical phenomena. Chem. Rev. 93:2395-2417.
36. Wang, J. M., P. Morin, W. Wang, and P. A. Kollman. 2001. Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. J. Am. Chem. Soc. 123:5221-5230.
37. Srinivasan, J., J. Miller, P. A. Kollman, and D. A. Case. 1998. Continuum solvate studies of stability of RNA hairpin loops and helices. J. Biomol. Struct. Dyn. 16:671-682.
38. Rocchia, W., E. Alexov, and B. Honig. 2001. Extending the applicability of the nonlinear Poisson-Boltzmann equation: multiple dielectric constants and multivalent ions. J. Phys. Chem. B. 105:6507-6514.
39. Connolly, M. L. 1983. Analytical molecular-surface calculation. J. Appl. Crystallogr. 16:548-558.
40. Gohlke, H., and D. A. Case. 2003. Converging free energy estimates: MM-Pb(GB)SA studies on the protein-protein complex Ras-Raf. J. Comput. Chem. 25:238-250.
41. Sitkoff, D., K. A. Sharp, and B. Honig. 1994. Accurate calculation of hydration free energies using macroscopic solvent models. J. Phys. Chem. 98:1978-1988.
42. McQuarrie, D. A. 1976. Statistical Mechanics. Harper & Row, New York.
43. Pearlman, D. A. 2005. Evaluating the molecular mechanics Poisson-Boltzmann surface area free energy method using a congeneric series of ligands to p38 MAP Kinase. J. Med. Chem. 48:7796-7807.
44. Boys, S. F., and F. Bernardi. 2002. The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors. (Reprinted from Molecular Physics, 1970, 19:553-566). Mol. Phys. 100:65-73.
45. Tauer, T. P., and C. D. Sherrill. 2005. Beyond the benzene dimer: an investigation of the additivity of π-π interactions. J. Phys. Chem. A. 109:10475-10478.
46. Ye, X. Y., Z. H. Li, W. Wang, K. Fan, W. Xu, and Z. Hua. 2004. The parallel π-π stacking: a model study with MP2 and DFT methods. Chem. Phys. Lett. 397:56-61.
47. Johnson, E. R., R. A. Wolkow, and G. A. DiLabio. 2004. Application of 25 density functionals to dispersion-bound homomolecular dimers. Chem. Phys. Lett. 394:334-338.
48. Zhang, D. W., and J. Z. H. Zhang. 2004. Full quantum mechanical ab initio computation of protein-molecule interaction energies. J. Theor. Comput. Chem. 3:43-49.
49. Mei, Y., C. G. Ji, and J. Z. H. Zhang. 2006. A new quantum method for electrostatic solvation energy of protein. J. Chem. Phys. 125:94906.